Professor of biology and chemistry at the University of Texas at San Antonio and the former dean of the College of Sciences. Editor-in-Chief of the Journal in Alzheimer’s Disease
Co-Chair of SBMT Alzheimer’s Subcommittee.
Dr. Perry’s studies are focused on the mechanism of formation and physiological consequences of the cytopathology of Alzheimer disease. The lab has shown that oxidative damage is the initial cytopathology in Alzheimer disease. They are working to determine the sequence of events leading to neuronal oxidative damage and the source of the increased oxygen radicals. Current studies focus on the:
The Society for Brain Mapping and Therapeutics (SBMT) was founded in 2004 to break boundaries in healthcare. The society promotes policies that support rapid, safe, and cost-effective translation of new technology into medicine.